Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.78 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-15983.3US
AY.78 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.78 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16933China
B.1.159NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.159NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.159NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.43.5 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.43.5 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.43.5 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.1.6.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBC.1.6.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.6.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FP.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FP.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.423NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.423NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.423NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.550NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.550NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.550NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.261NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.261NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.261NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.3.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.3.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.3.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EP.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EP.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EP.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.15.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.15.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.15.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCBNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCBNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCBNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.15.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.15.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.15.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.8.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CM.8.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used